Interferon beta-1b
RxNorm 72257
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 72257 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: interferon beta-1b.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Interferon beta-1b
(Atom ID: 627522)
PTPrescribable
Designated preferred name (PT):
Interferon beta-1b
(Atom ID: 627527)
FNPrescribable
Full form of descriptor (FN):
Interferon beta-1b (substance)
(Atom ID: 627544)
PTPrescribable
Designated preferred name (PT):
Interferon beta-1b-containing product
(Atom ID: 10805222)
FNPrescribable
Full form of descriptor (FN):
Product containing interferon beta-1b (medicinal product)
(Atom ID: 10307336)
Patient Education
Interferon Beta-1b Injection
Interferon beta-1b injection is used to reduce episodes of symptoms in patients with relapsing-remitting (course of disease where symptoms flare up from time to time) of multiple sclerosis (MS, a disease in which the nerves do not function properly and patients may experience weakness, numbness, loss of muscle coordination and problems with vision, speech, and bladder control). Interferon beta-1b is in a class of medications called immunomodulators. It is not known exactly how interferon beta-1b works to treat MS.
[Learn More]
* Please review the disclaimer below.